NYMOX PHARMACEUTICAL CORP — 20-F Filings
28 20-F filings on record
This page lists all 20-F filings submitted to the SEC by NYMOX PHARMACEUTICAL CORP (NYMXF), sorted by most recent first. Each row links to the full filing on EdgarLookup. NYMOX PHARMACEUTICAL CORP has filed 28 20-F documents with the SEC since 1996. To view all SEC filings by NYMOX PHARMACEUTICAL CORP, see the full filings list.
All
20-F
20-F/A
20FR12G
20FR12G/A
25-NSE
3
4
4/A
424B3
424B5
6-K
6-K/A
CORRESP
CT ORDER
EFFECT
F-1
F-1/A
F-3
F-3/A
NT 20-F
POS AM
SC 13D
SC 13G
SC 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 20-F | FORM 20-F | 0001640334-25-000972 | Jun 3, 2025 | Dec 31, 2024 |
| 20-F | FORM 20-F | 0001640334-24-001383 | Aug 29, 2024 | Dec 31, 2023 |
| 20-F | FORM 20-F | 0001640334-23-000736 | May 2, 2023 | Dec 31, 2022 |
| 20-F | FORM 20-F | 0001640334-22-000622 | Mar 30, 2022 | Dec 31, 2021 |
| 20-F | FORM 20-F | 0001640334-21-000680 | Mar 29, 2021 | Dec 31, 2020 |
| 20-F | FORM 20-F | 0001640334-20-000668 | Mar 30, 2020 | Dec 31, 2019 |
| 20-F | FORM 20-F | 0001640334-19-000464 | Mar 29, 2019 | Dec 31, 2018 |
| 20-F | FORM 20-F | 0001640334-18-000561 | Mar 30, 2018 | Dec 31, 2017 |
| 20-F | ANNUAL REPORT FOR THE FISCAL YEAR ENDED DECEMBER 31, 2016 | 0001176256-17-000083 | Mar 31, 2017 | Dec 31, 2016 |
| 20-F | ANNUAL REPORT FOR THE FISCAL YEAR ENDED DECEMBER 31, 2015 | 0001176256-16-000495 | Mar 31, 2016 | Dec 31, 2015 |
| 20-F | ANNUAL REPORT FOR THE FISCAL YEAR ENDED DECEMBER 31, 2014 | 0001176256-15-000122 | Mar 31, 2015 | Dec 31, 2014 |
| 20-F | ANNUAL REPORT FOR THE FISCAL YEAR ENDED DECEMBER 31, 2013 | 0001176256-14-000092 | Mar 14, 2014 | Dec 31, 2013 |
| 20-F | ANNUAL REPORT FOR THE FISCAL YEAR ENDED DECEMBER 31, 2012 | 0001176256-13-000165 | Mar 15, 2013 | Dec 31, 2012 |
| 20-F | ANNUAL REPORT FOR THE FISCAL YEAR ENDED DECEMBER 31, 2011 | 0001176256-12-000169 | Mar 15, 2012 | Dec 31, 2011 |
| 20-F | ANNUAL REPORT FOR THE FISCAL YEAR ENDED DECEMBER 31, 2010 | 0001176256-11-000215 | Mar 15, 2011 | Dec 31, 2010 |
| 20-F | ANNUAL REPORT FOR THE FISCAL YEAR ENDED DECEMBER 31, 2009 | 0001176256-10-000218 | Mar 11, 2010 | Dec 31, 2009 |
| 20-F | ANNUAL REPORT | 0001176256-09-000225 | Mar 13, 2009 | Dec 31, 2008 |
| 20-F | ANNUAL REPORT | 0000897069-08-000789 | Apr 28, 2008 | Dec 31, 2007 |
| 20-F | ANNUAL REPORT | 0000897069-07-001446 | Jun 26, 2007 | Dec 31, 2006 |
| 20-F | ANNUAL REPORT | 0000897069-06-001616 | Jun 30, 2006 | Dec 31, 2005 |
| 20-F | ANNUAL REPORT | 0000897069-05-001630 | Jun 30, 2005 | Dec 31, 2004 |
| 20-F | ANNUAL REPORT | 0000897069-04-001263 | Jun 30, 2004 | Dec 31, 2003 |
| 20-F | FORM 20-F | 0000897069-03-000605 | May 27, 2003 | Dec 31, 2002 |
| 20-F | FORM 20-F | 0000897069-02-000485 | Jun 27, 2002 | Dec 31, 2001 |
| 20-F | NYMOX PHARMACEUTICAL CORPORATION | 0000950123-01-502018 | May 8, 2001 | Dec 31, 2000 |
| 20-F | NYMOX PHARMACEUTICAL CORPORATION | 0000950123-00-005090 | May 15, 2000 | Dec 31, 1999 |
| 20-F | NYMOX PHARMACEUTICAL CORPORATION | 0000950123-99-004650 | May 14, 1999 | Dec 31, 1998 |
| 20-F | NYMOX PHARMACEUTICAL CORPORATION | 0000950123-98-004728 | May 8, 1998 | Dec 31, 1997 |